GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » Total Receivables

GRAIL (MEX:GRAL) Total Receivables : MXN517 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Total Receivables?

GRAIL's Total Receivables for the quarter that ended in Dec. 2024 was MXN517 Mil.


GRAIL Total Receivables Historical Data

The historical data trend for GRAIL's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Total Receivables Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Total Receivables
26.35 11.01 385.34 402.90 516.93

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 402.90 331.73 344.24 389.63 516.93

GRAIL Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


GRAIL Total Receivables Related Terms

Thank you for viewing the detailed overview of GRAIL's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


GRAIL Business Description

Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.